Saavedra, Ronald T.

HRN: 18-70-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/19/2025
12/25/2025
IV
500 Mg
Q 8 Hours
Amebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines